Literature DB >> 17080019

Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology.

Z L Qi1, X Huo, X J Xu, B Zhang, M G Du, H W Yang, L K Zheng, J Li, Z Y Shen.   

Abstract

AIM: To investigate the role of human papillomavirus (HPV) HPV16/18 E6 oncogene in the carcinogenesis of esophageal cell carcinoma (ESCC).
MATERIALS AND METHODS: Tissue microarray (TMA) block was constructed from 60 cases of paraffin-embedded ESCC tissues and pair-matched controls (adjacent normal epithelium). Immunohistochemistry (IHC) methods were applied to detect the expression of HPV16/18 E6, p53, p21(WAF1), MDM2, Ki67 and cyclin D1 proteins on TMA slides. In situ hybridization (ISH) targeting HPV gene was also used.
RESULTS: In ESCC samples, 18.3% (11/60) were revealed HPV16/18 E6 positive by IHC, while 40.0% (24/60) HPV positive by ISH; HPV16/18 E6 expression was significantly higher than that of control samples. In ESCC samples, the expressions of p53, p21(WAF1), Cyclin D1, MDM2 and Ki67 were recorded in 60.0% (36/60), 40.0% (24/60), 51.7% (31/60), 65.0% (39/60) and 88.3% (53/60) cases respectively, In ESCC samples, p53, MDM2 and Ki67 expression correlated with the HPV16/18 E6 expression (p less, similar 0.01), p21(WAF1) expression - with these of MDM2 and cyclin D1 (p less, similar 0.01) whilst expression of Ki67 - with ESCC grade (p less, similar 0.01).
CONCLUSION: HPV might be one of etiological factor of esophageal carcinoma in Shantou, China. p53, MDM2 proteins may play important roles in the pathogenesis of HPV-associated ESCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080019

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  6 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.

Authors:  O M Omran; M AlSheeha
Journal:  Pathol Oncol Res       Date:  2014-06-13       Impact factor: 3.201

3.  Synergistic tissue counterstaining and image segmentation techniques for accurate, quantitative immunohistochemistry.

Authors:  Simone P Zehntner; M Mallar Chakravarty; Rozica J Bolovan; Christopher Chan; Barry J Bedell
Journal:  J Histochem Cytochem       Date:  2008-06-23       Impact factor: 2.479

4.  Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.

Authors:  Donghong Zhang; Qingying Zhang; Li Zhou; Leijun Huo; Yi Zhang; Zhongying Shen; Yi Zhu
Journal:  BMC Cancer       Date:  2010-11-26       Impact factor: 4.430

Review 5.  Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta-analysis.

Authors:  H A Hardefeldt; M R Cox; G D Eslick
Journal:  Epidemiol Infect       Date:  2014-06       Impact factor: 4.434

6.  Characterization of p16 and E6 HPV-related proteins in uterine cervix high-grade lesions of patients treated by conization with large loop excision.

Authors:  Maria Teresa Roncaglia; José Humberto T G Fregnani; Maricy Tacla; Silvana Gisele Pegorin DE Campos; Hélio Hehl Caiaffa; Alexandre Ab'saber; Eduardo Vieira DA Motta; Venâncio Avancini Ferreira Alves; Edmund C Baracat; Adhemar Longatto Filho
Journal:  Oncol Lett       Date:  2013-05-20       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.